期刊文献+

术前营养风险对膀胱癌根治术患者预后的影响 被引量:3

The effect of preoperative nutritional risk on the prognosis of patients with bladder cancer after radical cystectomy
下载PDF
导出
摘要 目的:探讨术前营养风险对膀胱癌根治术患者预后的影响。方法:回顾性分析2010年02月至2018年05月我院泌尿外科收治的186例行根治性全膀胱切除术患者的临床资料。术前采用营养风险评估表(NRS-2002)筛查患者营养风险,根据NRS-2002评分结果将患者分为有营养风险组(总评分≥3分)96例和无营养风险组(总评分<3分)90例。比较两组患者临床资料;采用Kaplan-Meier模型对两组患者的肿瘤无复发生存期(recurrence free survival,RFS)和总生存期(overall survival,OS)进行分析;患者RFS和OS的独立危险因素采用多因素Cox比例风险回归模型分析。结果:有营养风险组和无营养风险组在病理T分期、肿瘤大小、是否淋巴结转移、肾积水方面比较差异有统计学意义(P<0.05);有营养风险组和无营养风组险5年RFS率分别为29.17%(28/96)、45.56%(41/90),5年OS率分别为43.75%(42/96)、58.89%(53/90);Kaplan-Meier分析结果显示,有营养风险组患者的RFS和OS均短于无营养风险组(P<0.05);Cox比例风险回归模型显示,术前营养风险是影响膀胱癌根治术患者RFS和OS的独立危险因素(P<0.05)。结论:术前有营养风险是膀胱癌根治术患者RFS和OS的独立危险因素,有营养风险的患者术后预后更差。 Objective:To explore the effect of preoperative nutritional risk on the prognosis of patients with bladder cancer after radical cystectomy.Methods:The clinical data of 186 patients with radical cystectomy admitted to department of urology surgery in our hospital from February 2010 to May 2018 were analyzed retrospectively.Nutritional Risk Screening-2002(NRS-2002)was used to screen the patients with bladder cancer for nutritional risk.According to the NRS-2002 score,the patients were divided into the group with nutritional risk(total score≥3 points,n=96)and the group without nutritional risk(total score<3 points,n=90).The clinical data between the two groups were compared.Kaplan-Meier method was used to analyze the recurrence free survival(RFS)and overall survival(OS)between the two groups.The independent risk factors of RFS and OS were analyzed by the multivariate Cox proportional risk regression model.Results:There were significant differences in pathological T stage,tumor size,lymph node metastasis and hydronephrosis between the group with nutritional risk and the group without nutritional risk(P<0.05).The 5-year RFS rates of the group with and without nutritional risk were 29.17%(28/96)and 45.56%(41/90),respectively.The 5-year OS rates of the group with and without nutritional risk were 43.75%(42/96)and 58.89%(53/90),respectively.Kaplan-Meier analysis showed that RFS and OS of patients with nutritional risk were shorter than those without nutritional risk(P<0.05).The Cox proportional risk regression model showed that preoperative nutritional risk was an independent risk factor for RFS and OS in bladder cancer patients undergoing radical cystectomy(P<0.05).Conclusion:Preoperative nutritional risk is an independent risk factor for RFS and OS in bladder cancer patients undergoing radical cystectomy.Patients with nutritional risk had worse prognosis.
作者 傅维琴 傅光华 钱文燕 FU Weiqin;FU Guanghua;QIAN Wenyan(Department of Urology Surgery,the First People's Hospital of Yibin,Sichuan Yibin 664000,China)
出处 《现代肿瘤医学》 CAS 北大核心 2022年第2期283-287,共5页 Journal of Modern Oncology
关键词 营养风险 膀胱癌 根治性膀胱切除术 预后 nutritional risk bladder cancer radical cystectomy prognosis
  • 相关文献

参考文献17

二级参考文献175

  • 1张薇,项永兵,邵常霞,方茹蓉,程家蓉,袁剑敏,高玉堂.吸烟和环境烟草烟雾暴露与膀胱癌关系的病例对照研究[J].肿瘤,2006,26(1):42-47. 被引量:14
  • 2蒋朱明,陈伟,江华,詹文华,陶晔璇,张澍田,蔡威.住院患者营养风险筛查指南[J].中国临床营养杂志,2007,15(1):13-15. 被引量:42
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Fernandez-Gomez J, Solsona E, Unda M, et al. Prog- nostic factors in patients with non-muscle-invasive blad- der cancer treated with bacillus Calmette-Guerin: mult- ivariate analysis of data form four randomized CUETO trials [J]. Eur Urol, 2008, 53(5): 992-1001.
  • 5Borden L S Jr, Clark P E, Hall M C. Bladder cancer [J]. Curr OpinOncot, 2004, 16(3): 257-262.
  • 6Manoharan M, Soloway M S. Optimal management of the T1G3 bladder cancer [J]. Urol Clin North Am, 2005, 32(2): 133-145.
  • 7Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder., a combined analysis of seven EORTC studies [J]. Eur Urol, 2002, 41(5): 523-531.
  • 8Lamm D L. Intravesical therapy for superficial bladder cancer: slow but steady progress [J]. J Clin Oncol, 2003,21(23) : 4259-4260.
  • 9Sylvester R J, Oosterlinck W, van der Meijden A P. A single immediate postoperative instillation of chemo- therapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer., a meta-analysis of pub- lished results of randomized clinical trials [J]. J Urol, 2004, 171(6 Pt 1): 2186-2190.
  • 10Babjuk M, Oosterlinck W, Sylvester R J, et al. EUA guidelines on non-muscle-invasive bladder cancer (Ta T1 and CIS)[M]. European Association of Urology, 2011.

共引文献342

同被引文献33

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部